Chemotherapy Induced Neutropenia Completed Phase 3 Trials for Doxorubicin (DB00997)

Also known as: Neutropenia post-chemotherapy / Chemotherapy-Induced Neutropenia / Chemotherapy Associated Neutropenia / Chemotherapy-induced neutropenia (disorder) / Neutropenia, unspecified / Neutropenia / Neutropenia (disorder) [Ambiguous] / Neutropenic disorder (disorder) / (Agranulocytosis) or (Kostmann's syndrome) or (neutropenia) / Neutropenias

IndicationStatusPhase
DBCOND0051348 (Chemotherapy Induced Neutropenia)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01126190Neugranin in Breast Cancer Participants Receiving Doxorubicin/DocetaxelSupportive Care